Research Compound Database

Also: GLOW Blend, GLOW Stack, GHK-Cu+BPC-157+TB-500

GLOW is a three-peptide research blend targeting skin rejuvenation, collagen synthesis, wound healing, and systemic tissue repair. The dominant component, GHK-Cu (50 mg), is one of the most researched skin-repair peptides known to activate over 4,000 genes involved in tissue remodeling. Combined with BPC-157's angiogenic and healing properties and TB-500's cell migration effects, GLOW targets beauty and regeneration at the cellular level.

Also: MT-1, Afamelanotide, CUV1647, Scenesse

Melanotan I (Afamelanotide) is an FDA Breakthrough Therapy and EU-approved (Scenesse) selective MC1R agonist used to prevent phototoxic skin reactions in patients with erythropoietic protoporphyria (EPP). Unlike Melanotan II, its linear structure and MC1R selectivity provide a more targeted and safer melanogenic effect.

Also: MT-2, Melanotan 2

Melanotan II is a potent non-selective melanocortin receptor agonist originally developed as a tanning agent. It produces rapid, deep skin pigmentation without UV exposure by activating melanocytes. It also has significant sexual function and appetite-suppressing effects through central melanocortin receptor activation.